In this thought leader article Orjana Terova, Melisa Carpio, Ian Flaherty, Robin Butler, Nico Tuason, and Christine Gebski from Repligen describe how disruptive technologies are improving efficiency ...

OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector ...

Despite advances in therapeutic approaches, lung cancer remains the leading cause of cancer-related deaths. To understand the molecular programs underlying lung cancer initiation and maintenance, we ...

SkyQuest projects that the Global Gene Therapy Market will reach a value of USD 38.34 Billion by 2031, with a CAGR of 19% during the forecast period (2024-2031).Numerous factors are responsible for ...